About this trial
Establish a high-quality clinical cohort of hyperglycemia in pregnancy. Develop subtype-specific, end-to-end standards for diagnosis, treatment, and follow-up across the preconception, pregnancy, and postpartum phases. These standards will lay a solid foundation for efficient, high-quality clinical research.
Eligibility criteria
Qualifiers
Pregnant individuals who provide written informed consent
Age ≥18 years at the time of consent
Willing and able to attend postpartum assessments (OGTT at 6 weeks, 12 months, and annually thereafter), with planned follow-up ≥3 years
Disqualifiers
Current or history of illicit drug use or substance abuse
Presence of an active infectious disease, including but not limited to: viral hepatitis, sexually transmitted infections or tuberculosis
Any other condition which, in the judgment of the investigator, would make the subject unsuitable for enrollment in the study
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Shanghai General Hospital, China
Lead sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Collaborator
Shanghai First Maternity and Infant Hospital
Collaborator
RenJi Hospital
Collaborator